Clinical Advisory Board

Joseph P. Broderick, MD

Joseph P. Broderick, MD, is Professor of Neurology and Rehabilitation Medicine at the University of Cincinnati College of Medicine and Director of the University of Cincinnati Gardner Neuroscience Institute. Dr. Broderick is an internationally recognized expert on the treatment and underlying causes of stroke. He currently is the Principal Investigator of the National Coordinating Center for the U.S. NIH funded network of stroke trials.

Read More
Professor Bruce Campbell

Professor Campbell, the head of stroke care at Royal Melbourne Hospital, is regarded as a leading international expert in stroke research and practice implementation. His research interests are focused on the imaging and treatment of acute stroke and he was co-principal investigator and medical coordinator of the EXTEND-IA and EXTEND-IA TNK multi-center randomized trials published in the New England Journal of Medicine in 2015 and 2018. He co-chairs the World Stroke Organization Young Stroke Professionals Committee.

Read More
Richard Becker, MD

Richard Becker, MD is Professor of Medicine and Director, Heart, Lung and Vascular Institute at The University of Cincinnati College of Medicine and an Adjunct Professor of Medicine at the Duke University School of Medicine. His experience as a physician-scientist spans the molecular, mechanistic and drug development perspectives of cardiovascular disease. He has served on multiple industry sponsored Scientific and Clinical Advisory Boards focused on the development of anti-thrombotic drugs and reversal agents.

Read More
Robert M. Califf, MD, MACC

Robert M. Califf, MD, MACC, is the Head of Clinical Policy and Strategy for Verily and Google Health. Prior to this Dr. Califf was the vice chancellor for health data science for the Duke University School of Medicine; director of Duke Forge, Duke’s center for health data science; and the Donald F. Fortin, MD, Professor of Cardiology. He served as Deputy Commissioner for Medical Products and Tobacco in the U.S. Food and Drug Administration (FDA) from 2015-2016, and as Commissioner of Food and Drugs from 2016-2017.

Read More
Pooja Khatri MD, MSc

Pooja Khatri MD, MSc is Professor of Neurology and Director of the Stroke Team at University of Cincinnati. She has had over 15 years of federal and industry funding, and specific expertise in developing stroke reperfusion therapies from conception to post-marketing. She co-directs the National Coordinating Center for the U.S. NIH StrokeNet.

Read More
Dr. Michael Hill

Dr. Michael Hill is a Professor for the Departments of Clinical Neurosciences, Community Health Sciences, Medicine and Radiology at the University of Calgary and Director of the Stroke Unit for the Calgary Stroke Program, Alberta Health Services. Dr. Hill’s research interests include stroke thrombolysis, stroke epidemiology, and surveillance and clinical trials. He is currently leads the largest ongoing Phase 3 trial in ischemic stroke.

Read More